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half an hour all our patients were well enough to be
left on their own.
If no ischaemic changes following accidental intra-
arterial injection are reported, and it can be shown
that the drug is not porphyrinogenic, it will become
a useful drug in the anaesthetist's armamentarium.
In conclusion we have found Althesin to be an accept-
able induction agent; but to be satisfactory as the sole
anaesthetic in short procedures only when the larger dose
is used.
We wish to thank our medical and nursing colleagues in
the Department of Gynaecology for their co-operation; Pro-
fessor A. B. Bull, Head of the Department of Anaesthetics,
for his encouragement; and Professor G. G. Harrison for his
help in the statistical analysis. We should also like to thank
Dr J. G. Burger, Medical Superintendent of Groote Schuur
Hospital, for permission to publish; and Glaxo-Allenburys
(pty) Ltd, for supplying the drug.
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SUMMARY
Renal function is commonly assessed by measurement of
910merular filtration rate (GFR). However, defects in tubu-
lar function may still exist in the presence of a normal
GFR. In 12 patients with systemic lupus erythematosus
(SLE), 6 of whom had previously been shown to have
renal impairment, glomerular and tubular function were
studied separately. In 4 patients, all parameters of renal
function tested were normal. Impaired tubular function
was found in 8 of the 12 patients, including 5 with normal
GFR. Defects were noted in the ability to acidify urine in
7 patients and tubular reabsorption of phosphate was
reduced in 2. A poor correlation was noted between the
presence of renal tubular acidosis and the serum y-globu-
lin level. The pathogenesis of the defect in urinary acidi-
fication in SLE and its prognostic significance are dis-
cussed.
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Subclinical disorders of renal tubular function have been
described in a variety of hypergammaglobulinaemic
conditions, including 'auto-immune' diseases such as
Sjogren's syndrome,'" systemic lupus erythematosus
(SLE),3 alveolitis' and chronic active hepatitis.' The
reported abnormalities of renal tubular function include
impairment of acid excretion and urinary concentration.
It has been suggested tbat the hypergammaglobulinaemic
state may be causaUy related to the tubular dysfunction.
The purpose of this investigation was to examine various
parameters of tubular and glomerular function in patients
with SLE, and to study the relationship between the
defects of renal function and the presence of
hypergammaglobulinaemia.
PATIENTS AND METHODS
Twelve patients (Table 1), 6 of whom were known to
have renal disease, were studied. There were 10 females
and 2 males, aged between 19 and 61 years. AU conformed
to Harvey's diagnostic criteria for SLE.· This permitted
the inclusion of a patient who had discoid lupus ery-
thematosus; haemolytic anaemia, polyarthritis and
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Fig. 1. Creatinine clearance (Ccr), tubular reabsorption of
phosphate (TRP) and maximum urinary osmolality
(OSM) 8 hours after injection of pitressin. Shaded are3.§
represent mean ± 2 SD of control values.
was reduced in 2 patients, neither of whom showed
evidence of hyperparathyroidism. Three patients were
unable to concentrate urine normally, as judged by
the maximal urine osmolality attained 6 - 8 hours after
the administration of pitressin tannate in oil.
The pattern of acid excretion in the presence of
systemic acidosis, induced with ammonium chloride,
is shown in Fig. 2. All 6 patients with clinical renal
disease had an impaired ability to lower urinary pH to
normal levels (normal range 4,68 - 5,19). In the 4 patients
who were unable to reduce pH below 5,40, TA production
was decreased. Ammonium excretion was also decreased
in 2 of these patients, but was normal when corrected
for urine pH. The 1 patient with systemic acidosis
present before acid loading died subsequently from
progressive renal failure. In 1 patient, who was able
Creatinine clearance was reduced in 3 patients (Fig. I),
the lowest being 26 mllmini 1,73 m'. Urinary protein
excretion was increased in 5 patients, 2 of whom had
the nephrotic syndrome. Defects in tubular function were
also present (Fig. 1). Tubular reabsorption of phosphate
RESULTS
nephritis, but no LE cells. Fourteen healthy volunteers,
aged 19 to 40 years, acted as controls.
The protocol used during the investigation followed
essentially that of the one-day renal function test of
Edwards et al.' This entailed the collection of a mid-
stream urine specimen for microscopy and culture, 2
arterial blood samples, and 2 3-hour timed urine
specimens, followed by a 2-hour urine collection.
Parameters of renal function measured included the
creatinine clearance, phosphate clearance, protein
excretion and the maximal urinary concentration attained
after the subcutaneous injection of 5 units of pitressin
tannate in oil. In addition, the ability to handle an
acid load was tested according to the short oral ammonium
chloride loading test of Wrong and Davies.8 Urine pH,
titratable acid (TA), ammonium and bicarbonate were
measured in the last 2 urine collections, and acid-base
studies were performed on arterial blood collected before,
and during the test. Total hydrogen ion excretion was
estimated as the sum of TA and ammonium, minus
bicarbonate.
Activity of the immune process was assessed by
estimation of total haemolytic complement. Urine pH
was measured at room temperature with a glass electrode
pH meter. TA was determined according to the method
of Wrong aHd Davies," urinary ammonia by the micro-
diffusion method of Conway; and urine bicarbonate by
the method of Van Slyke and Neill;'° employing the
Henderson-Hasselbalch equation. Urea, creatinine and
calcium were measured with the Technicon auto-analyser.
Urine osmolality was determined by means of an advanced
osmometer. Serum proteins were analysed by paper
electrophoresis. Total haemolytic complement was
measured according to a modification of the method
of Kent et at. ll
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DISCUSSION
being minimal in 2 cases. Of the 3 patients with low
complement levels and more severe defects, 2 have
subsequently died, 1 of renal failure. The other (who
was azotaemic and hypertensive) died at home, so the
cause of death could not be established. The third patient
is being maintained on chronic dialysis. Renal biopsies
were performed on 4 of the patients who were known to
have renal disease before entering this study, confirming
the clinical diagnosis of lupus nephritis.
Twelve patients with SLE were selected for this study.
In 6, renal impairment had been demonstrated previously.
At the time of the study, all parameters of renal function
tested were normal in 4 patients. Impaired tubular
function was found in 8 of the 12 patients, including
5 with normal glomerular filtration rates (GFR). Five
of the 12 patients exhibited proteinuria; all had abnormal
tubular function, while in only 3 was the GFR diminished.
The reduced reabsorption of phosphate found in 2
patients cannot be explained by parathyroid overactivity,
or by a reduction in the GFR. In 1 patient, the defect
could have been secondary to prednisone treatment,
.since it has been shown in dogs that corticosteroids
may inhibit the tubular reabsorption of phosphate.%> TA
production was reduced in 4 of the 6 patients who
failed to lower their urine pH to normal levels. Ammo-
nium production was normal in these patients, when
corrected for urine pH. One patient showed low TA
and ammonium excretion, but produced urine with a
pH in the normal range.
Several immune disorders have been described in
association with a renal tubular acidosis. These in-
clude multiple myeloma," Sjogren's syndrome,"""
hyperglobuIinaemic purpura," chronic active hepatitis'
and SLE.' In all these conditions, except multiple myeloma,
where a proximal renal tubular acidosis occurs, the
tubular acidosis is of the distal variety. Distal renal
tubular acidosis is characterized by a failure to produce
urine of low pH. The tubules are unable to excrete









F~ 2. Lowest urinary pH, greatest amount of titratable
acid (TA), ammonium (NIL), and total acid (Tot. Ac.)
excreted after an acid load. Shaded areas represent mean
± 2 SD of control values.
to lower urine pH to 5,12, total hydrogen ion production
was reduced as a result of impairment of excretion of
both TA and ammonium.
Glycosuria was found in 1 patient, who was known
to have diabetes mellitus, and who had no defect in
renal function. Urinary tract infection was detected in
1 patient, who demonstrated a trivial defect in acidification.
Total serum globulin was elevated in 7 patients and in
3 of these impaired acid excretion was present (Table II).
Serum y-globulins, however, were raised in only 2
patients. Thus an inconstant relationship existed between
renal tubular acidosis and serum y-globulin levels. Alpha.-
globulin was raised in the patient who demonstrated a
pattern of acid excretion similar to that found in chronic
renal failure.
Total haemolytic complement was reduced in 7 patients
(Table II), 2 of whom had no evidence of renal disease.
The other 5 had defects in acidification, the disorder
TABLE 11. SERUM PROTEINS
Globulins· Complement·
Patient LE (g/100 ml) Gammaglobulins· (C'HSO u/ml) Tubular function
1 + 2,2 1,6 46 Normal
2 3,9 1,8 294 Normal
3 I 3,3 1,6 161 NormalT
4
,
3,3 ND 217 NormalT
5 I 3,6 1,9 50 NormalT
8 4,0 1,9 217 Defective
7 2,5 1,4 217 Defective
8 + 1,7 1,4 86 Defective
9 + 3,7 2,6 0 Defective
10 + 4,1 2,6 128 Defective
11 + 2,5 1,4 109 Defective
12 2,5 1,0 24 Defective
• Normal: globulin: 1,5 - 3,0 g/l00 ml; gammaglobulin: 1,0 - 1,8 g/l00 ml; complement: 160 - 210 C'H50 u/mf.
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variety of renal tubular acidosis, TA excretion is impaired.
In the complete form, which is associated with a basal
systemic acidosis, ammonium excretion is also reduced,
but it is normal when corrected for urine pH. This was
seen in 1 of our patients (case 12), who subsequently
died of progressive renal failure. At the time of the
study, her creatinine clearance was 45 mljminj 1,73 m'
and, in view of the report by Elkinton," that acidosis
does not usually occur until glomerular filtration rate
is below 20 mljmin, it is unlikely that her acidosis was
due to generalized renal failure. In the incomplete variety
of renal tubular acidosis, found in 5 of our patients,
no systemic acidosis occurs and ammonium production,
when corrected for urine pH, is supranormal. Three of
these patients with distal renal tubular acidosis exhibited
another defect of distal tubular function, namely a
failure to concentrate urine normally.
In generalized renal failure, although urinary pH is
usually low, total acid excretion is reduced as a result
of impaired ammonium excretion and, to a lesser extent.
reduced TA excretion. The lowered TA production in
patients with generalized renal failure is secondary to
the reduced filtration of phosphate. One of our patients
(case 10) exhibited this pattern of acid excretion, but he
had relatively good renal function as judged by the crea-
tinine clearance of 82 mljmin/l,73 m'.
As renal tubular acidosis may also be secondary to
hyperparathyroidism, hypokalaemia, hypercalcaemia and
pyelonephritis, each patient was screened for evidence of
these conditions. In 2 patients with minimal defects in
acidification and normal GFRs, the disorder may possibly
have been secondary to a urinary tract infection in
one, and hypokalaemia in the other.
It has been suggested that the hypergammaglobulinaemia
found in 'auto-immune' diseases may be responsible for
the disturbance in acidification described in these
disorders."" Impairment of acid excretion could be
due to reabsorption of filtered globulins by the tubular
cells. Since the proximal tubule is the I!lajor site of
protein reabsorption, one would expect a proximal tubular
acidosis to occur. However, it is possible that globulins
could reach the distal tubular cells by leaking out of
peritubular capillaries, damaged by the immune process.
In cases of multiple myeloma associated with the
Fanconi syndrome, protein-like inclusion bodies have
been demonstrated in the proximal tubular cells.'" In
patients with distal tubular acidosis, however, inclusion
bodies have not been demonstrated in the distal tubules.
The possibility that hypergammaglobulinaemia may
impair circulation in the distal peritubular vessels either
by increasing viscosity or by producing a vasculitis,
has also been postulated.' However, no histological
evidence of vascular damage has been noted.'" It has
been suggested" that there may be specific antibodies,
reacting with tubular cells. In Sjogren's syndrome""'"
where peritubular infiltrates of round cells are prominent
in the kidney, immunoglobulin and complement deposits
have been described in the tubular cells of patients with
renal tubular acidosis. However, different workers"''''
have failed to detect immunoglobulins in tubular cells
of patients with hypergammaglobulinaemia due to other
causes.
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The occurrence of renal tubular acidosis in the absence
of hypergammaglobulinaemia in many of our patients.
leads us to believe that hypergammaglobulinaemia is
not the main factor producing this disturbance of renal
function. This is in agreement with the work of Tu and
Shearn: who also studied a group of patients with SLE.
However, Morris and Fudenberg" demonstrated a high
incidence of renal mbular acidosis in patients with
hypergammaglobulinaemia and Talal er al." found
significantly raised globulin levels in patients with renal
tubular acidosis.
It has been shown that a fall in serum complement
in SLE may herald the onset of an active phase of the
disease."'» It is commonly associated with renal involve-
ment and thus may be a guide to prognosis in SLE."
In our study, the combination of low serum complement
and renal tubular acidosis carried a particularly poor
prognosis, as 2 patients died, and the third is requiring
chronic dialysis.
This work fonned part of the programme of the MRCjUCT
Renal Metab{)lic Research Group which is supported by the
University of Cape Town and by the South African Medical
Research Council.
We wish to thank M. Levey, H. Page and R. Edelson for
able technical assistance; Dr J. G. Burger, for facilities
granted; and Dr O. L. Meyers for the serum complement
estimations.
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